

Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumatoid arthritis. However, these treatments remain symptomatic. Together with Janssen Pharmaceutica, world-renowned rheumatologist Lars Klareskog is ready to take the research and treatment of inflammatory joint disease to the next level.
June 12, 2017 · Janssen PharmaceuticaFive entirely synthetic yeast chromosomes were created this year. By 2018 every chromosome is expected to have a synthetic couterpart, resulting in en entirely synthetic genome.
May 22, 2017 · BioVox